Stock Events

Stock Events

ReproCELL Incorporated 

$1.25
13
+$0+0% Tuesday 12:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
118.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

20MayExpected
Q2 2025
Q3 2025
Q4 2025
Next
-0.02
-0.01
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

3.36%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
40.13MRevenue
1.35MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RECLF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sthree
STEM.LSE
Mkt Cap200.73M
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides comprehensive life sciences solutions, including cell culture media and services, competing in the biotechnology product space.
Illumina
ILMN
Mkt Cap18.99B
Illumina offers genomic sequencing and analysis, competing with ReproCELL's services in genetic testing and personalized medicine.
Agenus
AGEN
Mkt Cap126.5M
Agenus is involved in immuno-oncology, a field that overlaps with ReproCELL's work in cell-based therapies.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that compete with ReproCELL's offerings in life sciences and healthcare.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applying technologies that compete with ReproCELL's genetic analysis services.
Repligen
RGEN
Mkt Cap8.39B
Repligen offers bioprocessing technologies and systems, competing in the broader biotech and pharmaceutical manufacturing sector.
Bio-Techne
TECH
Mkt Cap9.74B
Bio-Techne develops and manufactures innovative biotech products and services, including those for cell and gene therapy research.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences provides genomic analysis systems, competing in the genomics and genetic analysis sector.

About

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, and synfire induced neurons; 3D cell culture; and labware. The company also provides research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, diagnostic, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.
Show more...
CEO
Country
JP
ISIN
JP3974770004

Listings

OTC Link
US
RECLF
TSE
JP
4978.TSE
F
DE
6RC.F

0 Comments

Share your thoughts

FAQ

What is ReproCELL Incorporated stock price today?▼
The current price of RECLF is $1.25 USD — it has increased by +0% in the past 24 hours. Watch ReproCELL Incorporated stock price performance more closely on the chart.
What is ReproCELL Incorporated stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ReproCELL Incorporated stocks are traded under the ticker RECLF.
What is ReproCELL Incorporated market cap?▼
Today ReproCELL Incorporated has the market capitalization of 118.18M
When is the next ReproCELL Incorporated earnings date?▼
ReproCELL Incorporated is going to release the next earnings report on May 20, 2026.
What were ReproCELL Incorporated earnings last quarter?▼
RECLF earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ReproCELL Incorporated revenue for the last year?▼
ReproCELL Incorporated revenue for the last year amounts to 40.13M USD.
What is ReproCELL Incorporated net income for the last year?▼
RECLF net income for the last year is 1.35M USD.
When did ReproCELL Incorporated complete a stock split?▼
ReproCELL Incorporated has not had any recent stock splits.